Novo Nordisk A/S stock price
NVO
#55

₺2.173,41
  

7.11%

Novo Nordisk A/S Info

Piyasa değ.
₺9,63T

7.11%

Günlük Hacim
₺7,44B
Varlık türü
Hisse S.
Çalışanlar
78387
Kuruluş
Dec 21, 1923
Temel borsa
New York Stock Exchange
CIK numarası
0000353278

Tokenize Hisse Verileri

Ort. Tokenize Fiyat
₺2,22K
Fiyat Farkı
+₺50,39(+2.32%)
Tokenize Piy. Değ.
₺179,63M

7.28%

Tokenize Hac. (24s)
₺49,95M

7.48%

İhraççı
Sözleşmeler
Gezginler
NVO/USD Dönüştürücü
NVO
TRY
Fiyat performansı
Düşük
₺1,99K
Yüksek
₺2,19K

Veriler Yükleniyor

Grafik verilerini yüklüyoruz, lütfen bekleyin

Novo Nordisk A/S topluluğu

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S Fiyatı Canlı Veri

The current price of Novo Nordisk A/S in the market is ₺2.173,41, with a 24-hour trading volume of ₺7,44B. The asset's market cap is ₺9,63T, after moving 7.11% in the last day.

Tokenized Novo Nordisk A/S is trading at ₺2.223,8, with a tokenized market cap of ₺179,63M and a 24-hour trading volume of ₺49,95M. The tokenized asset has moved 7.28% in the past 24 hours.